A Clinical and Market Analysis
Molluscum contagiosum affects an estimated 6 million Americans each year, predominantly children between the ages of 1 and 10. Despite two FDA approvals since 2023, a meaningful clinical gap remains and the practice patterns that have long defined pediatric MC management have not yet caught up with the science.
